Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

The 2019 suggested that patients with nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. However, the performance of noninvasive clinical models/scores and plasma biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) and advanced fibrosis has not been care...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2020-02, Vol.43 (2), p.290-297
Hauptverfasser:	Bril, Fernando, McPhaul, Michael J, Caulfield, Michael P, Clark, Virginia C, Soldevilla-Pico, Consuelo, Firpi-Morell, Roberto J, Lai, Jinping, Shiffman, Dov, Rowland, Charles M, Cusi, Kenneth
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers Biomarkers - blood Biopsy Cross-Sectional Studies Cytokeratin Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - diagnosis Diagnosis Diagnostic systems Disease Progression Fatty liver Female Fibrosis Humans Liver Liver - diagnostic imaging Liver - pathology Liver Cirrhosis - blood Liver Cirrhosis - complications Liver Cirrhosis - diagnosis Liver Cirrhosis - pathology Liver diseases Magnetic Resonance Spectroscopy Male Medical diagnosis Middle Aged Non-alcoholic Fatty Liver Disease - blood Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - pathology Panels Patients Plasma Predictive Value of Tests Procollagen Reproducibility of Results Research design
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!